• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[持续性非卧床腹膜透析还有未来吗?]

[Does CAPD have a future?].

作者信息

Maher J F

出版信息

Z Urol Nephrol. 1987 Apr;80(4):229-37.

PMID:3307213
Abstract

Five decades were between the first clinical use of the peritoneal dialysis and the introduction of the continuous ambulant peritoneal dialysis (CAPD)-five decades with many problems and little acceptance of this technique by patients and physicians. Greater week clearances in the CAPD led to a significant increase of the effectiveness in comparison to intermittent therapeutic forms, so that the popularity of this method of treatment rapidly increased. A simple technical handling and the patient's independence of the machine essentially contribute to the popularity of the CAPD. Significant results in the combat against peritonitis, the main problem of the CAPD, made the CAPD a recognized method of treatment for the terminal renal insufficiency. Should not unforeseeable innovations decisively improve the technique of haemodialysis, the CAPD will maintain its position beside the haemodialysis also in the following decade.

摘要

从腹膜透析首次临床应用到持续性非卧床腹膜透析(CAPD)的引入历经了五十年——这五十年间该技术存在诸多问题,患者和医生对其接受度也很低。与间歇性治疗方式相比,CAPD更大的每周清除率显著提高了治疗效果,因此这种治疗方法的普及率迅速上升。操作简单以及患者无需依赖机器这两点是CAPD普及的重要因素。在对抗CAPD的主要问题——腹膜炎方面取得的显著成果,使CAPD成为终末期肾功能不全的一种公认治疗方法。如果不可预见的创新不能决定性地改进血液透析技术,那么在接下来的十年里,CAPD在血液透析之外仍将保持其地位。

相似文献

1
[Does CAPD have a future?].[持续性非卧床腹膜透析还有未来吗?]
Z Urol Nephrol. 1987 Apr;80(4):229-37.
2
[Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].[持续性非卧床腹膜透析(CAPD)在慢性肾功能不全治疗方案中的作用。CAPD转为移植或血液透析所带来的问题]
Nephrologie. 1995;16(1):129-35.
3
[The future of life support measures in terminal renal failure].[终末期肾衰竭生命支持措施的未来]
Schweiz Rundsch Med Prax. 1986 Feb 25;75(9):211-2.
4
[Active treatment of uremia in the study county of Vejle. Epidemiology 1979-1994 and future perspectives].
Ugeskr Laeger. 1996 Jun 24;158(26):3759-63.
5
[Experiences with continuous ambulatory peritoneal dialysis (CAPD) at the University Clinic for Internal Medicine in Innsbruck].[因斯布鲁克大学内科诊所持续性非卧床腹膜透析(CAPD)的经验]
Wien Klin Wochenschr. 1983 Mar 4;95(5):168-71.
6
Renal transplantation in patients on continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者的肾移植
Proc Eur Dial Transplant Assoc. 1981;18:222-7.
7
[Development of peritoneal dialysis at Rijeka Clinical Hospital Center].[里耶卡临床医院中心腹膜透析的发展]
Acta Med Croatica. 2004;58(3):215-20.
8
[Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].[持续性非卧床腹膜透析或维持性血液透析的慢性肾衰竭患者多发性神经病变严重程度的评估]
Przegl Lek. 2007;64(6):423-30.
9
Successful use of continuous ambulatory peritoneal dialysis (CAPD) in the treatment of patients with renal and cardiac failure.
Tokai J Exp Clin Med. 1986 Oct;11(4):279-83.
10
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.